Innovative solutions to the greatest challenges in pharmaceutical development

21 - 23 March 2022

The AGENDA for the 13th Global Drug Delivery & Formulation Summit is now live!

The 2022 Summit covers small molecules and biologicsnew technologies, concepts and case studies in areas such as:

  • Formulation design for poorly soluble compounds
  • The potential of nanotechnology for better deliverability
  • The latest controlled released technologies
  • Improving patient compliance by harnessing data and the latest smart device technology
  • Optimising formulations for continuous manufacturing
  • Overcoming the blood brain barrier and challenges in oral delivery of biologics
  • Reformulation and biosimilars

BOOK FOR €895

2022 Speakers

Sune Andersen

Janssen

Principal Scientist in Particle Engineering

Jean-Rene Authelin

Sanofi

Global Head of Pharmaceutical Engineering

Dr. Fatima Bennai-Sanfourche

Bayer

Director Medical Device Safety, Medical Device Safety Officer

Dr. Andreas Bernkop-Schnürch

Innsbruck University

Head of the Department Center for Chemistry and Biomedicine

Jeffrey T. Blue

MSD

Executive Director, Vaccine Drug Product Development PR&D

Joshua Boateng

University of Greenwich

Professor in Pharmaceutics and Drug Delivery, School of Science

Stefanie Dohrn

AbbVie

Senior Scientist

Naila El-kechai

Sanofi

Formulation and Drug Product Team Leader

Paulina Luisa Fischer

AbbVie

PhD Student

Patrick Garidel

Boehringer Ingelheim

Head of Process, Purification and Pharma Development

Helen Hao Hou

Genentech

Principal Scientist Small Molecule Pharmaceutical Sciences

Ben Van Hove

Janssen

Associate Director Drug Product Development, Oral Solid Dosage Forms

Martin Huelsmeyer

AbbVie

Head of HTS Operations & Analytics

Ajay J. Khopade

Sun Pharma Advanced Research

Vice President-R&D, Formulation Development (Non-Orals)

Samuel Kyeremateng

Abbvie

NCE Formulation Sciences Senior Scientist

Philippe Lienard

Sanofi

Early Development Coordinator

Dr. Manfred Ogris

University of Vienna

Professor Department of Pharmaceutical Sciences

Mikolaj Milewski

MSD

Principal Scientist

Mostafa Nakach

Sanofi

Head of formulation and Process development

Rene Van Nostrum

Utrecht University

Associate Professor, Pharmaceutical sciences

Rick Panicucci

QED

Senior Vice President CMC

John C. Shelley

Schrödinger

Fellow

Vivek Trivedi

University of Kent

Lecturer in Drug Delivery, Medway School of Pharmacy

Matthias  Gerhard Wacker

National University of Singapore

Associate Professor

Kerstin Walke

Boehringer Ingelheim

Head of Pharmaceutical Development Biologicals

Latest News

Nanoform’s Clinical Study Indicates Positive Interim Results

Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announced positive interim results from its clinical study. The faster absorption data implies that small particles can indeed be powerful.

Silicones for drug infusion devices - From hospital to wearable: how silicones are used at different scales to help patients live a normal life

This e-book presents an overview of the medical, industrial, compliance and economic advantages and challenges in the use of silicone materials in Infusion as a method of drug delivery. The unique properties of silicones along with their longstanding, proven track record in medical applications, can enable innovative solutions that improve the quality and efficacy of infusion care.

PMC Isochem To accelerate Polyamino acids Business as part of ISODEL® Drug Delivery offer, a unique One Stop Shop for NCA and PAA

PMC Isochem announces today that it is accelerating the strategic development and manufacture of polyamino acids (PAA) as functional excipients used in complex formulations and drug delivery solutions. Based on its own internal resources and endowed with a fully integrated know-how as well as its leading position in the manufacture of critical Activated Amino Acids (NCA), PMC Isochem becomes the reliable supplier of PAA and the sustainable partner.